Concepedia

Jane Nagel

JN

4

Publications

2.3K

Citations

4

H-Index

2007

Active since

Affiliations

Harvard University(Current)

Novartis (Switzerland)

Novartis Institutes for BioMedical Research

Jane Nagel is an author at Harvard University specializing in medicine, cell signaling, and oxidative stress.

Top concepts

Publications per year

2007–2014

4

Publications

4

Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide

Eric S. Fischer, Kerstin Böhm, John R. Lydeard et al. · Nature · 2014 · 1K citations · Full text

Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

William E. Dowdle, Beat Nyfeler, Jane Nagel et al. · Nature Cell Biology · 2014 · 715 citations

, , +13

Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses

Sheli R. Radoshitzky, Jonathan Abraham, Christina F. Spiropoulou et al. · Nature · 2007 · 437 citations · Full text

, , +6

Quantitative Lys-ϵ-Gly-Gly (diGly) Proteomics Coupled with Inducible RNAi Reveals Ubiquitin-mediated Proteolysis of DNA Damage-inducible Transcript 4 (DDIT4) by the E3 Ligase HUWE1

Joel W. Thompson, Jane Nagel, Sjouke Hoving et al. · Journal of Biological Chemistry · 2014 · 69 citations · Full text

Rows per page

1–4 of 4